mutation_id	virus	genotype	gene	drug	aa_change	fold_change	sarscov2_polyprot	sarscov2_polyprot_pos	sarscov2_protein	sarscov2_protein_pos	Notes	judy_class	struc_notes_homology	struc_notes_mutataion_impact	ref_title	ref_doi	status
1	SARS-CoV-2		NSP12	Remdesivir	E802D	2.14	orf1ab	5195	NSP12	E802D	FDA showed sensitive to molnupiravir https://www.fda.gov/media/155054/download	5-sensitive homologous	good	paper: minor structural modification of NSP12 that potentially influences the position of C813 and S814	Szemiel 2021	doi.org/10.1371/journal.ppat.1009929	A
2	SARS-CoV-2		NSP12	Remdesivir	E802A	2.54	orf1ab	5195	NSP12	E802A		3-homologous nuc' resmut observed once	good	paper: minor structural modification of NSP12 that potentially influences the position of C813 and S814	Szemiel 2021	doi.org/10.1371/journal.ppat.1009929	A
3	murine hepatitis virus		rdrp	Remdesivir	F476L	2.4	orf1ab	4873	NSP12	F480L	FDA showed sensitive to molnupiravir https://www.fda.gov/media/155054/download	5-sensitive homologous	good	can shift cat res 691	Agostini 2018	doi.org/10.1128/mBio.00221-18	A
4	murine hepatitis virus		rdrp	Remdesivir	V553L	5	orf1ab	4950	NSP12	V557L	FDA showed sensitive to molnupiravir https://www.fda.gov/media/155054/download	5-sensitive homologous	good	interacts with ssrna coming in	Agostini 2018	doi.org/10.1128/mBio.00221-18	A
5	murine hepatitis virus		rdrp	Remdesivir	"F476L + V553L	"	5.6	orf1ab		NSP12	F480L + V557L	FDA showed sensitive to molnupiravir https://www.fda.gov/media/155054/download	5-sensitive homologous	good	can shift cat res 691	Agostini 2018	doi.org/10.1128/mBio.00221-18	A
6	SARS-CoV		rdrp	Remdesivir	F476L + V553L	6	orf1ab		NSP12	F480L + V557L	FDA showed sensitive to molnupiravir https://www.fda.gov/media/155054/download	5-sensitive homologous	good		Agostini 2018	doi.org/10.1128/mBio.00221-18	A
7	Venezuelan equine encephalitis virus		NSP4	Molnupiravir-metabolite	I190T	2		4836	NSP12	A443	A201I & V308I  cause reversion to sensitivity ie compensatory mutations	1-proven sars antiviral resistance	poor	new hbond to 293 -> unclear moa . in sars2 unsure	Urakova 2018	doi.org/10.1128/JVI.01965-17	A
8	Venezuelan equine encephalitis virus		NSP4	Molnupiravir-metabolite	P187S	0.3	orf1ab	4835	NSP12	F442		1-proven sars antiviral resistance	ok		Urakova 2018	doi.org/10.1128/JVI.01965-17	A
9	Venezuelan equine encephalitis virus		NSP4	Molnupiravir-metabolite	A189T	5	orf1ab	4939	NSP12	Y546		1-proven sars antiviral resistance	ok-ish	interacts with dsrna maybe via 291	Urakova 2018	doi.org/10.1128/JVI.01965-17	A
10	Venezuelan equine encephalitis virus		NSP4	Molnupiravir-metabolite	A189V	20	orf1ab	4939	NSP12	Y546		1-proven sars antiviral resistance	ok-ish	interacts with dsrna maybe via 291	Urakova 2018	doi.org/10.1128/JVI.01965-17	A
11	Influenza A	Eng15	rdrp	Favipiravir	K229R	R	orf1ab	4938	NSP12	K545	Equivalent position found in Naydenova 2021	2-homologous nuc' resmut observed more than once	good	Reported good - alters favi binding pocket forces it into a conformation	Goldhill 2018	doi.org/10.1073/pnas.1811345115	A
12	chikungunya		rdrp	Favipiravir	K291R	R	orf1ab	4938	NSP12	K545	Equivalent position found in Naydenova 2021	2-homologous nuc' resmut observed more than once	good	Well characterised as resistance causing in many viruses, alters conformation of catalytic residues	Delang 2014	doi.org/10.1093/jac/dku209	A
13	Human Enterovirus	EV71	rdrp	Favipiravir	S121N	R	orf1ab	4900	NSP12	N507		2-homologous nuc' resmut observed more than once	ok	Binds incoming rna chain, i.e. may specifically alter favi binding specificity	Wang 2016	doi.org/10.1128/AAC.01073-16	A
14	Norovirus	GOSH	rdrp	Favipiravir	A44S	NA	orf1ab	4836	NSP12	A443	mutants feasibly occur under Favi treatment seen with mol	2-homologous nuc' resmut observed more than once	difficult		UCL Internal	NA	A
15	Norovirus	GOSH	rdrp	Favipiravir	K103R	NA	orf1ab	4881	NSP12	I488	mutants feasibly occur under Favi treatment	4-non-homologous	NA		UCL Internal	NA	A
16	Norovirus	GOSH	rdrp	Favipiravir	S198A	NA	orf1ab	4964	NSP12	F571	mutants feasibly occur under Favi treatment	3-homologous nuc' resmut observed once	good		UCL Internal	NA	A
17	Norovirus	GOSH	rdrp	Favipiravir	I274T	NA	orf1ab	5047	NSP12	R654	mutants feasibly occur under Favi treatment	3-homologous nuc' resmut observed once	ok		UCL Internal	NA	A
18	Norovirus	GOSH	rdrp	Favipiravir	A312T	NA	orf1ab	5087	NSP12	F694	mutants feasibly occur under Favi treatment	3-homologous nuc' resmut observed once	good		UCL Internal	NA	A
19	Norovirus	GOSH	rdrp	Favipiravir	I332V	NA	orf1ab	5142	NSP12	L749	mutants feasibly occur under Favi treatment	3-homologous nuc' resmut observed once	ok-ish		UCL Internal	NA	A
20	Norovirus	RUIS	rdrp	Favipiravir	N18S	NA					mutants feasibly occur under Favi treatment	4-non-homologous	NA		UCL Internal	NA	O
21	Poliovirus type 1	Mahoney	rdrp	Ribavirin	G64S	3	orf1ab	4852	NSP12	N459		2-homologous nuc' resmut observed more than once	ok-ish	Unsure	Pfeiffer 2003, Pfeiffer 2014	doi.org/10.1073/pnas.1232294100 doi.org/10.1073/pnas.1232294100	A
22	Human Enterovirus	EV71	rdrp	Ribavirin	G64N	S	orf1ab	4855	NSP12	T462		5-sensitive homologous	Questionable	Unsure quite near cat	Sadeghipour 2013	doi.org/10.1128/JVI.02139-12	A
23	Human Enterovirus	EV71	rdrp	Ribavirin	G64R	93	orf1ab	4855	NSP12	T462		2-homologous nuc' resmut observed more than once	Questionable	Unsure quite near cat	Sadeghipour 2013, Meng 2014	doi.org/10.1128/JVI.02139-12 doi.org/10.1128/JVI.00289-14	A
24	foot-and-mouth disease virus		rdrp	Ribavirin	R84H	1.2	orf1ab	4871	NSP12	K478		3-homologous nuc' resmut observed once	good		Zeng 2013	doi.org/10.1016/j.antiviral.2013.07.008	A
25	Coxsackie virus B3		rdrp	Ribavirin	S299T	S	orf1ab	5085	NSP12	S692		3-homologous nuc' resmut observed once	good	near cat res 691 & 760. Hbond to 759 altered / steric bulk shifts cat res	Levi 2010	doi.org/10.1371/journal.ppat.1001163	A
26	Human Enterovirus	EV71	rdrp	Ribavirin	L123F	37	orf1ab	4902	NSP12	W509		2-homologous nuc' resmut observed more than once	ok		Meng 2014	doi.org/10.1128/JVI.00289-14	A
27	Human Enterovirus	EV71	rdrp	Ribavirin	G64R + L123F	535	orf1ab	463902	NSP12	N459 + W509		2-homologous nuc' resmut observed more than once	Questionable	Unsure quite near cat	Meng 2014	doi.org/10.1128/JVI.00289-14	A
28	chikungunya virus	06-049	rdrp	Ribavirin	C483A	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok Cysteine isnt obviously bound to something else which may be why many mutations are allowed. L786 is the most sensible homologous site	contacts 619, 618 is catalytic.	Coffey 2011	doi.org/10.1073/pnas.1111650108	A
29	Human Hepaitis C		NS5A	Ribavirin	E442G	r							not rdrp	NA	Pfeiffer 2005	doi.org/10.1128/JVI.79.4.2346-2355.2005	O
30	Human Hepaitis C		NS5A	Ribavirin	G404S	r							not rdrp	NA	Pfeiffer 2005	doi.org/10.1128/JVI.79.4.2346-2355.2005	O
31	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	A38V	high fidelity same sensitivity	orf1ab	4836	NSP12	A443	To discuss seen with mol	2-homologous nuc' resmut observed more than once	Questionable	Unsure	Zeng 2014	doi.org/10.1128/JVI.03594-13	A
32	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	D5N	high fidelity same sensitivity	orf1ab	4789	NSP12	F396	To discuss	3-homologous nuc' resmut observed once	Questionable	Unsure	Zeng 2014	doi.org/10.1128/JVI.03594-13	A
33	foot-and-mouth disease virus		rdrp	Ribavirin	M296I	R	orf1ab	5073	NSP12	T680		3-homologous nuc' resmut observed once	good	Alterations here likely shift cat res 691	Arias 2008	doi.org/10.1128/JVI.01297-08	A
34	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	M194I	r	orf1ab	4963	NSP12	Q570		3-homologous nuc' resmut observed once	good	Unsure	Li 2018	doi.org/10.1016/j.virol.2018.01.030	A
35	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	A122T	r	orf1ab	4900	NSP12	N507		2-homologous nuc' resmut observed more than once	ok	In fmdv this allows a new H-bond interaction with Q160 right where a rna single strand enters. In sars2 this interraction exists, and breaking it may have the resistance effect	Li 2018	doi.org/10.1016/j.virol.2018.01.030	A
36	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	R440W	r	orf1ab	5275	NSP12	H882		3-homologous nuc' resmut observed once	ok-ish	Away from anything catalytic hard to tell	Li 2018	doi.org/10.1016/j.virol.2018.01.030	A
37	foot-and-mouth disease virus	Asia1	rdrp	Ribavirin	A122T + M194I + M296I + R440W	R					mutants never tested  in isolation	4-non-homologous	NA	NA	Li 2018	doi.org/10.1016/j.virol.2018.01.030	O
38	chikungunya virus	06-049	rdrp	Ribavirin	C483F	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
39	chikungunya virus	06-049	rdrp	Ribavirin	C483G	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
40	chikungunya virus	06-049	rdrp	Ribavirin	C483I	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
41	chikungunya virus	06-049	rdrp	Ribavirin	C483L	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
42	chikungunya virus	06-049	rdrp	Ribavirin	C483M	8	orf1ab	5179	NSP12	L786		2-homologous nuc' resmut observed more than once	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
43	chikungunya virus	06-049	rdrp	Ribavirin	C483N	18	orf1ab	5179	NSP12	L786		2-homologous nuc' resmut observed more than once	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
44	chikungunya virus	06-049	rdrp	Ribavirin	C483Q	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
45	chikungunya virus	06-049	rdrp	Ribavirin	C483T	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
46	chikungunya virus	06-049	rdrp	Ribavirin	C483V	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
47	chikungunya virus	06-049	rdrp	Ribavirin	C483W	S	orf1ab	5179	NSP12	L786		5-sensitive homologous	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
48	chikungunya virus	06-049	rdrp	Ribavirin	C483Y	20	orf1ab	5179	NSP12	L786		2-homologous nuc' resmut observed more than once	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
49	chikungunya virus		rdrp	Ribavirin	C483Y	10	orf1ab	5179	NSP12	L786		2-homologous nuc' resmut observed more than once	ok	contacts 619, 618 is catalytic.	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
50	Sindbis virus	pTR339	rdrp	Ribavirin	C483A	S	orf1ab	5180	NSP12	Y787		5-sensitive homologous	good	unsure	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
51	Sindbis virus	pTR339	rdrp	Ribavirin	C483G	S	orf1ab	5180	NSP12	Y787		5-sensitive homologous	good	unsure	Vignuzzi 2014	doi.org/10.1371/journal.ppat.1003877	A
52	murine hepatitis virus		rdrp	Molnupiravir	K160E	R	orf1ab	4553	NSP12	K160	x30 conserved x other coronaviruses. No evidence resist				Sheahan 2020	NA	O
53	murine hepatitis virus		rdrp	Molnupiravir	A234T	R	orf1ab	4627	NSP12	V234	x30 Recurrent fixed mutation in multiple passaged lines				Sheahan 2020	NA	O
54	murine hepatitis virus		rdrp	Molnupiravir	T552I	R	orf1ab	4949	NSP12	T556	x30 Conserved across multiple coronaviruses. No evidence resist				Sheahan 2020	NA	O
55	MERS-CoV		NSP12	Molnupiravir	V558I	R	orf1ab	4953	NSP12	V560	x30 Recurrent fixed mutation in multiple passaged lines				Sheahan 2020	NA	O
56	foot-and-mouth disease virus		rdrp	Ribavirin	P44S		orf1ab		NSP12	NA	ÂºP187S in VEEV	5-sensitive homologous	NA - FMDV has extra loop compared to sars2	NA		NA	U
57	Ebola			Remdesivir	F548S	4					not rdrp					NA	U
58	Ebola				T562A	2					not rdrp					NA	U
59	West Nile virus	NY99	NS5 (rdrp)	Ribavirin	G806R										Van Slyke 2015	doi.org/10.1371/journal.ppat.1005010	O
60	West Nile virus	NY99	NS5 (rdrp)	Ribavirin	V793I										Van Slyke 2015	doi.org/10.1371/journal.ppat.1005010	O
61	Poliovirus type 1	Mahoney	rdrp	Ribavirin	G64A	R	orf1ab	4852	NSP12	N459		2-homologous nuc' resmut observed more than once	ok-ish	Unsure	Vignuzzi 2008	10.1038/nm1726	A
62	Poliovirus type 1	Mahoney	rdrp	Ribavirin	G64T	R	orf1ab	4852	NSP12	N459		2-homologous nuc' resmut observed more than once	ok-ish	Unsure	Vignuzzi 2008	10.1038/nm1726	A
63	Poliovirus type 1	Mahoney	rdrp	Ribavirin	G64V	r	orf1ab	4852	NSP12	N459		2-homologous nuc' resmut observed more than once	ok-ish	Unsure	Vignuzzi 2008	10.1038/nm1726	A
64	Poliovirus type 1	Mahoney	rdrp	Ribavirin	G64L	r	orf1ab	4852	NSP12	N459		2-homologous nuc' resmut observed more than once	ok-ish	Unsure	Vignuzzi 2008	10.1038/nm1726	A
65	Influenza A		PB1	Ribavirin	D27N	R	orf1ab	5236	NSP12	F843		3-homologous nuc' resmut observed once	ok	Unsure	Binh 2014	10.1016/j.bbrc.2013.12.071	A
66	Coxsackie virus B3	Nancy	rdrp	Ribavirin	A372V	2	orf1ab	5201	NSP12	G808		2-homologous nuc' resmut observed more than once	ok 808 or/and 809. A372 maintains hydrophobic environemnt with 229 and 225. 808 does the same with 606 and 614	unknkown - loss of hphobic pocket can shift but to what end?	Levi 2010	10.1371/journal.ppat.1001163	A
67	 St. Louis encephalitis virus		rdrp	Ribavirin	E416K	R		4901	NSP12	K508		2-homologous nuc' resmut observed more than once	poor	Forms bridge to 289 which may stericly restrict ssrna input to pol	Griesemer 2017	doi.org/10.1099/jgv.0.000682	A
68	 St. Louis encephalitis virus		rdrp	Favipiravir	E416K	R		4901	NSP12	K508		2-homologous nuc' resmut observed more than once	poor	Forms bridge to 289 which may stericly restrict ssrna input to pol	Griesemer 2017	doi.org/10.1099/jgv.0.000682	A
69	Coxsackie virus B3		rdrp	Ribavirin	A372V	R	orf1ab	5201	NSP12	G808		2-homologous nuc' resmut observed more than once	ok 808 or/and 809. A372 maintains hydrophobic environemnt with 229 and 225. 808 does the same with 606 and 614	unknkown - loss of hphobic pocket can shift but to what end?	Beaucourt 2011	https://doi.org/10.3791/2953	A
70	porcine reproductive and respiratory syndrome virus		rdrp	Ribavirin	A283T	R	orf1ab	4888	NSP12	V495		3-homologous nuc' resmut observed once	ok-ish	allows new hopnd to gln306 all near ssdna 	Tian 2016	doi.org/10.1099/jgv.0.000316	A
71	porcine reproductive and respiratory syndrome virus		rdrp	Ribavirin	H421Y	R	orf1ab	5035	NSP12	H642		3-homologous nuc' resmut observed once	ok	in that noro cluster region	Tian 2016	doi.org/10.1099/jgv.0.000316	A
72	Coxsackie virus	B3	rdrp	Ribavirin	F364W	10	orf1ab	5189	NSP12	E796		3-homologous nuc' resmut observed once	not but occupies same space	Larger sidechain forc	McDonald 2016	doi.org/10.1074/jbc.M116.726596	A
73	Poliovirus type 1		rdrp	Ribavirin	K359R	R	orf1ab	5191	NSP12	K798	catalytic pocket	4-non-homologous	none	Very close to 798 in sars2, likely this is catalytic in polio	Weeks 2012	doi.org/10.1074/jbc.C112.401471	A
74	Influenza A		PB1	Ribavirin	V43I	R	orf1ab	4849	NSP12	Y456		3-homologous nuc' resmut observed once	good	Unsure	Cheung 2014	doi.org/10.1038/ncomms5794	A
75	Influenza A		PB1	Ribavirin	V191I	r				None		4-non-homologous	NA	NA	Cheung 2014	doi.org/10.1038/ncomms5794	O
76	Influenza A		PB1	Ribavirin	A661T	r				None		4-non-homologous	NA	NA	Cheung 2014	doi.org/10.1038/ncomms5794	O
77	Influenza A		PB1	Ribavirin	S741F	r				None		4-non-homologous	NA	NA	Cheung 2014	doi.org/10.1038/ncomms5794	O
78	Poliovirus type 1	Sabin	rdrp	Favipiravir	N18S	1.5	orf1ab	4797	NSP12	N404		3-homologous nuc' resmut observed once	poor	Unsure	Daikoku 2017	doi.org/10.1016/j.jmii.2017.03.004	A
79	Poliovirus type 1	Sabin	rdrp	Favipiravir	K139R	1.3	orf1ab	4913	NSP12	S520		4-non-homologous	NA		Daikoku 2017	doi.org/10.1016/j.jmii.2017.03.004	O
80	Poliovirus type 1		rdrp	Ribavirin	K126A	S	orf1ab	4904	NSP12	K511		5-sensitive homologous	good	interacts ssrna entering	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
81	Poliovirus type 1		rdrp	Ribavirin	R128A	S	orf1ab	4906	NSP12	R513		5-sensitive homologous	good	interacts 498 which can widen / narrow the ssrna entry depending on if bond broken or enhanced	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
82	Poliovirus type 1		rdrp	Ribavirin	K133A	S						4-non-homologous	no	no	Kempf 2016	doi.org/10.1128/JVI.00078-16	O
83	Poliovirus type 1		rdrp	Ribavirin	K276A	S	orf1ab	5063	NSP12	G670		5-sensitive homologous	good	near ssrna entry again	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
84	Poliovirus type 1		rdrp	Ribavirin	N409A	S	orf1ab	5247	NSP12	L854		5-sensitive homologous	ok	interacts with dsrna	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
85	Poliovirus type 1		rdrp	Ribavirin	D412A	S	orf1ab	5250	NSP12	E857		5-sensitive homologous	good	interacts with dsrna	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
86	Poliovirus type 1		rdrp	Ribavirin	S416A	S	orf1ab	5254	NSP12	S861		5-sensitive homologous	good		Kempf 2016	doi.org/10.1128/JVI.00078-16	A
87	Poliovirus type 1		rdrp	Ribavirin	L419A	S	orf1ab	5257	NSP12	I864		5-sensitive homologous	good		Kempf 2016	doi.org/10.1128/JVI.00078-16	A
88	Poliovirus type 1		rdrp	Ribavirin	L420A	S	orf1ab	5258	NSP12	D865		5-sensitive homologous	good	interacts with ssrna coming in	Kempf 2016	doi.org/10.1128/JVI.00078-16	A
89	SARS-CoV-2		NSP12	Favipiravir	K798	cat	orf1ab	5191	NSP12	K798	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
90	SARS-CoV-2		NSP12	Favipiravir	D618	cat	orf1ab	5011	NSP12	D618	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
91	SARS-CoV-2		NSP12	Favipiravir	D761	cat	orf1ab	5154	NSP12	D761	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
92	SARS-CoV-2		NSP12	Favipiravir	D760	cat	orf1ab	5153	NSP12	D760	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
93	SARS-CoV-2		NSP12	Favipiravir	N691	cat	orf1ab	5084	NSP12	N691	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
94	SARS-CoV-2		NSP12	Favipiravir	K621	cat	orf1ab	5014	NSP12	K621	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
95	SARS-CoV-2		NSP12	Favipiravir	D623	cat	orf1ab	5016	NSP12	D623	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
96	SARS-CoV-2		NSP12	Favipiravir	S682	cat	orf1ab	5075	NSP12	S682	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
97	SARS-CoV-2		NSP12	Natural NTP	K545	cat	orf1ab	4938	NSP12	K545	Catalytic pocket	6-catalytic site	same virus		Peng 2021	doi.org/10.1016/j.xinn.2021.100080	A
98	Human Enterovirus	EV71	rdrp	Ribavirin	G64T	R	orf1ab	4855	NSP12	T462		2-homologous nuc' resmut observed more than once	Questionable	Unsure quite near cat	Sadeghipour 2013	doi.org/10.1128/JVI.02139-12	A
99	Human Enterovirus	EV71	rdrp	Ribavirin	S264L	R	orf1ab	5048	NSP12	L655		3-homologous nuc' resmut observed once	655-657	Unsure	Sadeghipour 2013	doi.org/10.1128/JVI.02139-12	A
100	SARS-CoV-2		NSP12	Remdesivir	E802D	R	orf1ab	5195	NSP12	E802D		2-homologous nuc' resmut observed more than once	same virus		Gandhi 2021	doi.org/10.1101/2021.11.08.21266069	A
101	SARS-CoV-2		NSP12	Remdesivir	D484Y	R	orf1ab	4877	NSP12	D484Y	only observed in serially treated patient ned more data				Martinot 2020	doi.org/10.1093/cid/ciaa1474	O
102	SARS-CoV-2		NSP12	Molnupiravir	S759	cat	orf1ab	5152	NSP12	S759	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
103	SARS-CoV-2		NSP12	Molnupiravir	A688	cat	orf1ab	5081	NSP12	A688	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
104	SARS-CoV-2		NSP12	Molnupiravir	N691	cat	orf1ab	5084	NSP12	N691	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
105	SARS-CoV-2		NSP12	Molnupiravir	T687	cat	orf1ab	5080	NSP12	T687	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
106	SARS-CoV-2		NSP12	Molnupiravir	S682	cat	orf1ab	5075	NSP12	S682	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
107	SARS-CoV-2		NSP12	Molnupiravir	D760	cat	orf1ab	5153	NSP12	D760	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
108	SARS-CoV-2		NSP12	Molnupiravir	D623	cat	orf1ab	5016	NSP12	D623	Catalytic pocket	3-catalytic site			Padhi 2020	doi.org/10.1016/j.isci.2020.101992	A
109	SARS-CoV-2		3clpro	Nirmatrelvir	G15S	4.4	orf1ab	3282	3clpro	G15S		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
110	SARS-CoV-2		3clpro	Nirmatrelvir	T135I	3.5	orf1ab	3402	3clpro	T135I		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
111	SARS-CoV-2		3clpro	Nirmatrelvir	S144A	91.9	orf1ab	3411	3clpro	S144A		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
112	SARS-CoV-2		3clpro	Nirmatrelvir	H164N	6.4	orf1ab	3431	3clpro	H164N		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
113	SARS-CoV-2		3clpro	Nirmatrelvir	H172Y	233	orf1ab	3439	3clpro	H172Y		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
114	SARS-CoV-2		3clpro	Nirmatrelvir	Q189K	65.4	orf1ab	3456	3clpro	Q189K		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
115	SARS-CoV-2		3clpro	Nirmatrelvir	D248E	3.7	orf1ab	3515	3clpro	D248E		1-proven sars antiviral resistance			FDA paxlovid fact sheet	https://www.fda.gov/media/155050/download	A
116	Norovirus	GOSH	rdrp	Favipiravir	I193V	NA	orf1ab	4959	NSP12	M566	mutants feasibly occur under Favi treatment seen with mol	3-homologous nuc' resmut observed once	good		UCL Internal	NA	A
117	Norovirus	GOSH	rdrp	Favipiravir	L259M	NA	orf1ab	5029	NSP12	L636	mutants feasibly occur under Favi treatment	3-homologous nuc' resmut observed once	good	Must be same MOA at 655 as it closely contacts it, any mutation alters helix-helix conformation	UCL Internal	NA	A
